Sign Out
Organ transplantation: Prophylaxis of organ rejection concomitantly with cyclosporine and corticosteroids in patients receiving allogeneic renal, cardiac or hepatic transplants.
Mofecon-C 250/Mofecon 500 is indicated for the treatment of first or refractory organ rejection in patients receiving allogeneic renal transplants.
Mofecon-C 250/Mofecon 500 is indicated for the prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplant. (In the treated population, MMF improved survival in the first year after transplantation.)
Mofecon-C 250/Mofecon 500 is indicated for the prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.
Mofecon-C 250/Mofecon 500 is indicated for induction and maintenance therapy of patients with Class III-IV lupus nephritis (diagnosed according to International Society of Nephrology/Renal Pathology Society classification).
Continue with Google